Table 3. Case summaries of the subjects having significant rejection after heart transplant.
| # | Patients | Significant rejection | Manage | sST2 (ng/mL) | NT-proBNP (pg/mL) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age | Sex | Etiology | Immunosuppressant | Grade | Time (month) | Pre | Rejection | Post | Pre | Rejection | Post | ||
| 1 | 44 | F | ICMP | PK | H | 0 | R | - | 337* | 154 | - | - | - |
| 2 | 26 | F | CTx | PMK | H | 1 | R | 84 | 105 | 18 | - | - | 2271.0 |
| 3 | 47 | M | Rejection | PMC | 2R | 2 | Steroid | 48 | 16 | 14 | 986.1 | 290.1 | 231.3 |
| 4 | 18 | M | DCMP | PMC | 2R | 2 | Steroid | 257* | 110* | 43 | - | 1912.0 | - |
| 5 | 57 | F | DCMP | PMK | 2R | 2 | MMF | 82* | 43 | 19 | 21061 | 17353 | 1731 |
| 6-1 | 25 | M | Rejection | PC | 2R | 2 | Steroid | 134* | 34 | 205* | - | 3327.0 | 973.8 |
| 7 | 43 | M | DCMP | PMC | H | 3 | R | 145* | 360* | 238* | 9010.0 | - | - |
| 8 | 62 | M | DCMP | PMK | 2R | 4 | Steroid | 14 | 12 | 20 | - | 528.1 | |
| 9 | 68 | F | DCMP | PMC | 2R | 4 | MMF | 31 | 31 | 107* | - | 1310.0 | 1352.0 |
| 10 | 25 | M | DCMP | PK | 3R | 4 | Steroid | 7 | 105* | - | 705.6 | 33061.0 | - |
| 11 | 63 | F | HCMP | PK | 2R | 4 | Steroid | 38 | 50* | 51* | 1560.0 | 3391.0 | 966.9 |
| 12 | 37 | F | DCMP | PMK | 2R | 5 | Steroid | 25 | 10 | 50* | 427.6 | 2868.0 | 1016.0 |
| 13 | 31 | F | HCMP | PMK | 2R | 6 | MMF | 19 | 12 | 17 | 554.6 | 498.3 | 686.7 |
| 14 | 34 | M | DCMP | PMC | 2R | 7 | MMF | 66* | - | - | 363.3 | - | - |
| 15 | 65 | F | DCMP | PK | 3R | 9 | Steroid | 14 | 29* | 136* | 1211.0 | 5189.0 | - |
| 16 | 60 | F | ICMP | PK | 2R | 10 | Steroid | 21 | - | - | 1834.0 | - | - |
| 17 | 66 | F | ICMP | PMC | 2R | 18 | MMF | - | 38* | 24* | - | 870.5 | 558.2 |
| 18 | 53 | M | DCMP | PMK | 2R | 18 | MMF | 19 | 32* | 15 | 336.5 | 202.1 | 251.4 |
| 6-2 | 25 | M | DCMP | PMC | 2R | 23 | Steroid | - | 27* | 34* | - | 501.6 | 233.6 |
| 19 | 29 | M | Rejection | PMK | 2R | 33 | Steroid | - | 27* | 23 | - | 132.9 | 310.0 |
*Indicates sST2 values above 2 standard deviations derived from entire population of all 494 blood samples at the same time point. F: female, M: male, ICMP: ischemic cardiomyopathy, CTx: chemotherapy induced cardiomyopathy, DCMP: dilated cardiomyopathy, HCMP: hypertrophic cardiomyopathy, P: prednisolone, M: mycophenolate, C: cyclosporine, K: tacrolimus, H: humoral rejection, R: rituximab, MMF: increasing dose of mycophenolate to 2 g/day